...
search icon
phat-img

Phathom Pharmaceuticals Inc Share Price

PHAT
NSQ
$11.88
-$0.88
(-6.9%)
1D
Industry: Pharmaceuticals Sector: Health Care

Phathom Pharmaceuticals Inc Analyst Forecast

Phathom Pharmaceuticals Inc Share Price Chart

Phathom Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$995.45M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.13M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.50
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.21 L
$18.31 H
$11.88

About Phathom Pharmaceuticals Inc, Common Stock

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Phathom Pharmaceuticals Inc Stock Returns

Time FramePHATSectorS&P500
1-Week Return-2.86%0.72%-1.31%
1-Month Return-16.04%1.27%0.78%
3-Month Return-20.8%3.13%3.46%
6-Month Return17.62%15.81%6.19%
1-Year Return107.69%8.89%11.68%
3-Year Return25.58%20.79%71.21%
5-Year Return-73.67%35.89%74.81%
10-Year Return-51.71%138.44%256.59%

Phathom Pharmaceuticals Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue---682.00K55.25M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":1.23,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue300.00K521.00K620.00K167.00K7.97M[{"date":"2020-12-31","value":3.76,"profit":true},{"date":"2021-12-31","value":6.53,"profit":true},{"date":"2022-12-31","value":7.78,"profit":true},{"date":"2023-12-31","value":2.09,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(300.00K)(521.00K)(620.00K)515.00K47.28M[{"date":"2020-12-31","value":-0.63,"profit":false},{"date":"2021-12-31","value":-1.1,"profit":false},{"date":"2022-12-31","value":-1.31,"profit":false},{"date":"2023-12-31","value":1.09,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin---75.51%85.57%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":88.25,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses125.36M134.56M171.82M167.83M324.75M[{"date":"2020-12-31","value":38.6,"profit":true},{"date":"2021-12-31","value":41.44,"profit":true},{"date":"2022-12-31","value":52.91,"profit":true},{"date":"2023-12-31","value":51.68,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(125.67M)(135.08M)(172.44M)(167.31M)(277.47M)[{"date":"2020-12-31","value":-12566500000,"profit":false},{"date":"2021-12-31","value":-13508000000,"profit":false},{"date":"2022-12-31","value":-17244000000,"profit":false},{"date":"2023-12-31","value":-16731200000,"profit":false},{"date":"2024-12-31","value":-27746700000,"profit":false}]
Total Non-Operating Income/Expense(6.89M)(15.55M)(50.46M)(68.37M)(113.71M)[{"date":"2020-12-31","value":-689300000,"profit":false},{"date":"2021-12-31","value":-1555000000,"profit":false},{"date":"2022-12-31","value":-5045600000,"profit":false},{"date":"2023-12-31","value":-6837200000,"profit":false},{"date":"2024-12-31","value":-11371000000,"profit":false}]
Pre-Tax Income(129.07M)(143.88M)(197.72M)(201.59M)(334.33M)[{"date":"2020-12-31","value":-12906800000,"profit":false},{"date":"2021-12-31","value":-14388300000,"profit":false},{"date":"2022-12-31","value":-19772300000,"profit":false},{"date":"2023-12-31","value":-20159200000,"profit":false},{"date":"2024-12-31","value":-33432600000,"profit":false}]
Income Taxes4.25M4.21M25.28M41.78M-[{"date":"2020-12-31","value":10.17,"profit":true},{"date":"2021-12-31","value":10.08,"profit":true},{"date":"2022-12-31","value":60.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(133.32M)(148.09M)(223.01M)(243.37M)-[{"date":"2020-12-31","value":-13331800000,"profit":false},{"date":"2021-12-31","value":-14809400000,"profit":false},{"date":"2022-12-31","value":-22300600000,"profit":false},{"date":"2023-12-31","value":-24337200000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(129.07M)(143.88M)(197.72M)(201.59M)(334.33M)[{"date":"2020-12-31","value":-12906800000,"profit":false},{"date":"2021-12-31","value":-14388300000,"profit":false},{"date":"2022-12-31","value":-19772300000,"profit":false},{"date":"2023-12-31","value":-20159200000,"profit":false},{"date":"2024-12-31","value":-33432600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(129.07M)(143.88M)(197.72M)(201.59M)(334.33M)[{"date":"2020-12-31","value":-12906800000,"profit":false},{"date":"2021-12-31","value":-14388300000,"profit":false},{"date":"2022-12-31","value":-19772300000,"profit":false},{"date":"2023-12-31","value":-20159200000,"profit":false},{"date":"2024-12-31","value":-33432600000,"profit":false}]
EPS (Diluted)(3.86)(3.89)(5.05)(3.88)(5.35)[{"date":"2020-12-31","value":-386,"profit":false},{"date":"2021-12-31","value":-389,"profit":false},{"date":"2022-12-31","value":-505,"profit":false},{"date":"2023-12-31","value":-388,"profit":false},{"date":"2024-12-31","value":-535,"profit":false}]

Phathom Pharmaceuticals Inc Ratios

Phathom Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

PHAT
Cash Ratio 1.45
Current Ratio 2.23
Quick Ratio 2.19

Phathom Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PHAT
ROA (LTM) -42.54%
ROE (LTM) -3489.00%

Phathom Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PHAT
Debt Ratio Lower is generally better. Negative is bad. 2.76
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.76

Phathom Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PHAT
Trailing PE NM
Forward PE NM
P/S (TTM) 6.76
P/B 25.37
Price/FCF NM
EV/R 6.88
EV/Ebitda NM

FAQs

What is Phathom Pharmaceuticals Inc share price today?

Phathom Pharmaceuticals Inc (PHAT) share price today is $11.88

Can Indians buy Phathom Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Phathom Pharmaceuticals Inc (PHAT) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PHAT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Phathom Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Phathom Pharmaceuticals Inc (PHAT) via the Vested app. You can start investing in Phathom Pharmaceuticals Inc (PHAT) with a minimum investment of $1.

How to invest in Phathom Pharmaceuticals Inc shares from India?

You can invest in shares of Phathom Pharmaceuticals Inc (PHAT) via Vested in three simple steps:

  • Click on Sign Up or Invest in PHAT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Phathom Pharmaceuticals Inc shares
What is Phathom Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Phathom Pharmaceuticals Inc (PHAT) is $18.31. The 52-week low price of Phathom Pharmaceuticals Inc (PHAT) is $2.21.

What is Phathom Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Phathom Pharmaceuticals Inc (PHAT) is

What is Phathom Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Phathom Pharmaceuticals Inc (PHAT) is 25.37

What is Phathom Pharmaceuticals Inc dividend yield?

The dividend yield of Phathom Pharmaceuticals Inc (PHAT) is 0.00%

What is the Market Cap of Phathom Pharmaceuticals Inc?

The market capitalization of Phathom Pharmaceuticals Inc (PHAT) is $995.45M

What is Phathom Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Phathom Pharmaceuticals Inc is PHAT

How Can Investors Use Phathom Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Phathom Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Phathom Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Phathom Pharmaceuticals Inc shares for Indian investors?

When investing in Phathom Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Phathom Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Phathom Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Phathom Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Phathom Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top